It is best studied that the mitogen-activated protein kinase (MAPK) pathway stimulates the activity of AP-1, in TRAF2-deficient NPC cells, and the decrease of ERK1/2 phosphorylation was observed. The gene discussed is WNK2; the disease is nasopharyngeal carcinoma.